Authors
Bridgewater, JPalmer, D
Cunningham, D
Iveson, T
Gillmore, R
Waters, J
Harrison, M
Wasan, H
Corrie, P
Valle, Juan W
Affiliation
UCL Cancer Institute, University College London, Gower Street, London WC1E 6BT, United KingdomIssue Date
2013-04
Metadata
Show full item recordCitation
Outcome of second-line chemotherapy for biliary tract cancer. 2013, 49 (6):1511 Eur J CancerJournal
European Journal of CancerDOI
10.1016/j.ejca.2012.11.024PubMed ID
23265701Type
ArticleLanguage
enISSN
1879-0852ae974a485f413a2113503eed53cd6c53
10.1016/j.ejca.2012.11.024
Scopus Count
Collections
Related articles
- Response to letter 'outcome of second-line chemotherapy for biliary tract cancer'.
- Authors: Walter T, Horgan AM, McNamara M, McKeeve L, Min T, Hedley D, Serra S, Krzyzanowska MK, Chen E, Mackay H, Feld R, Moore M, Knox JJ
- Issue date: 2013 Apr
- Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
- Authors: Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Barber S, Ryder WD, Ramage J, Davies LM, Bridgewater JA, Valle JW, Advanced Biliary Cancer Working Group
- Issue date: 2021 May
- Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers: A Multicenter Retrospective Population-based Cohort Study.
- Authors: Zaidi A, Chandna N, Narasimhan G, Moser M, Haider K, Chalchal H, Shaw J, Ahmed S
- Issue date: 2021 Mar 1
- Improvement of prognosis for unresectable biliary tract cancer.
- Authors: Sasaki T, Isayama H, Nakai Y, Takahara N, Sasahira N, Kogure H, Mizuno S, Yagioka H, Ito Y, Yamamoto N, Hirano K, Toda N, Tada M, Omata M, Koike K
- Issue date: 2013 Jan 7
- Current status of chemotherapy for the treatment of advanced biliary tract cancer.
- Authors: Sasaki T, Isayama H, Nakai Y, Koike K
- Issue date: 2013 Sep